Terms of Employment Offer, dated December 15, 2022, for Dana T. Aftab, Ph.D
Contract Categories:
Human Resources
- Employment Agreements
EX-10.20 2 exel20221230exhibit1020.htm EX-10.20 Document
Exhibit 10.20
TERMS OF EMPLOYMENT – DANA T. AFTAB
(as of December 15, 2022)
TITLE: Executive Vice President, Discovery and Translational Research, and Chief Scientific Officer
ANNUAL BASE SALARY: $560,000.22 annually
BONUS TARGET: 50% of Annual Base salary
INITIAL RESTRICTED STOCK UNIT (RSU) AWARD: 100,000 shares of Exelixis, Inc. common stock pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The vesting schedule for this RSU award is 1/4th on the first established RSU vesting date following the one year anniversary of the grant date (the “Initial RSU Vesting Date”) and 1/4th of the original number of shares subject to the RSU award on each succeeding annual anniversary of the Initial RSU Vesting Date until fully-vested, provided that vesting ceases upon termination of “continuous service” with Exelixis, Inc., as such term is defined in the Exelixis, Inc. 2017 Equity Incentive Plan.
